Thomas P Bersot

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol
    Thomas P Bersot
    Gladstone Institute, Koç American Hospital, Istanbul, Turkey, and Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, California, USA
    Anadolu Kardiyol Derg 2:315-22. 2002
  2. ncbi Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol
    Thomas P Bersot
    Gladstone Institute, American Hospital, Istanbul, Turkey
    Am Heart J 146:1052-9. 2003
  3. ncbi Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults
    Ahmet Selcuk Can
    Division of Endocrinology and Metabolism, Department of Medicine, Private Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey
    Public Health Nutr 13:488-95. 2010
  4. ncbi Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults
    Ahmet Selcuk Can
    From the Department of Medicine, Faculty of Medicine, Istanbul Science University, Istanbul, Turkey
    J Cardiometab Syndr 4:26-32. 2009
  5. ncbi Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults
    Ahmet Selcuk Can
    Department of Medicine, Istanbul Science University, Faculty of Medicine, Sisli, Istanbul, Turkey
    Public Health Nutr 12:538-46. 2009
  6. ncbi Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins
    Robert W Mahley
    Gladstone Institute of Cardiovascular Disease, San Francisco, California
    Am J Cardiol 96:547-55. 2005
  7. ncbi Antibody phenotyping test for the human apolipoprotein E2 isoform
    Robert L Raffai
    The Gladstone Institute of Cardiovascular Disease, Cardiovascular Research Institute, University of California, San Francisco, CA 94141 9100, USA
    Clin Chem 49:1524-6. 2003
  8. ncbi Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study
    Ahmet Selcuk Can
    Department of Medicine, Istanbul Science University, Faculty of Medicine, Esentepe, Sisli, Istanbul, Turkey
    BMC Public Health 7:353. 2007
  9. ncbi Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project)
    Diego F Wyszynski
    Department of Medicine (Genetics Program, Boston University School of Medicine, Boston, MA, USA
    Am J Cardiol 95:194-8. 2005
  10. ncbi Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC)
    Ralph V Shohet
    Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Hum Mutat 19:536-42. 2002

Collaborators

Detail Information

Publications12

  1. ncbi Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol
    Thomas P Bersot
    Gladstone Institute, Koç American Hospital, Istanbul, Turkey, and Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, California, USA
    Anadolu Kardiyol Derg 2:315-22. 2002
    ..The most effective drug treatment available presently in Turkey relies on lowering LDL-C levels to optimize the TC/HDL-C ratio...
  2. ncbi Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol
    Thomas P Bersot
    Gladstone Institute, American Hospital, Istanbul, Turkey
    Am Heart J 146:1052-9. 2003
    ..Twenty percent of male patients with CHD in the United States fall into this category. The total cholesterol/HDL-C (TC/HDL-C) ratio predicts CHD risk regardless of the absolute LDL-C and HDL-C...
  3. ncbi Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults
    Ahmet Selcuk Can
    Division of Endocrinology and Metabolism, Department of Medicine, Private Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey
    Public Health Nutr 13:488-95. 2010
    ..To identify the optimal waist:height ratio (WHtR) cut-off point that discriminates cardiometabolic risk factors in Turkish adults...
  4. ncbi Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults
    Ahmet Selcuk Can
    From the Department of Medicine, Faculty of Medicine, Istanbul Science University, Istanbul, Turkey
    J Cardiometab Syndr 4:26-32. 2009
    ..Other national health organizations should avoid using homeostasis model assessment as a prerequisite for diagnosing MS. Modification of the NCEP definition would be more appropriate for ethnic groups with different body sizes...
  5. ncbi Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults
    Ahmet Selcuk Can
    Department of Medicine, Istanbul Science University, Faculty of Medicine, Sisli, Istanbul, Turkey
    Public Health Nutr 12:538-46. 2009
    ..To identify the best anthropometric index that predicts cardiometabolic risk factors.Design and settingCross-sectional study in Turkey, in 2003...
  6. ncbi Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins
    Robert W Mahley
    Gladstone Institute of Cardiovascular Disease, San Francisco, California
    Am J Cardiol 96:547-55. 2005
    ..Why education failed to affect the HDL cholesterol levels in Turkish men remains unclear...
  7. ncbi Antibody phenotyping test for the human apolipoprotein E2 isoform
    Robert L Raffai
    The Gladstone Institute of Cardiovascular Disease, Cardiovascular Research Institute, University of California, San Francisco, CA 94141 9100, USA
    Clin Chem 49:1524-6. 2003
  8. ncbi Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study
    Ahmet Selcuk Can
    Department of Medicine, Istanbul Science University, Faculty of Medicine, Esentepe, Sisli, Istanbul, Turkey
    BMC Public Health 7:353. 2007
    ....
  9. ncbi Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project)
    Diego F Wyszynski
    Department of Medicine (Genetics Program, Boston University School of Medicine, Boston, MA, USA
    Am J Cardiol 95:194-8. 2005
    ..In subjects aged <35 years, atherogenic dyslipidemia frequently occurs in the absence of other metabolic syndrome risk factors...
  10. ncbi Sources of variability in genetic association studies: insights from the analysis of hepatic lipase (LIPC)
    Ralph V Shohet
    Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
    Hum Mutat 19:536-42. 2002
    ..Three novel LIPC polymorphisms were identified in the study (-1596insC, -2740A>G, and -2880G>C)...
  11. ncbi Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia
    Yi Yu
    Department of Medicine (Genetics Program, Boston University School of Medicine, Boston, MA, USA
    J Lipid Res 46:2202-13. 2005
    ..These data also indicate that a large proportion of the variance of TG levels in the Turkish population is explained by the interaction of multiple genetic loci...
  12. ncbi High density lipoprotein cholesterol in coronary artery patients: is it as low as expected?
    Robert W Mahley
    Anadolu Kardiyol Derg 6:94-6; author reply 96. 2006